Genelux (GNLX) Non-Current Assets (2022 - 2026)
Genelux's (GNLX) quarterly Non-Current Assets came in at $5.6 million in Q1 2026, up 44.16% quarter-over-quarter from $3.9 million in Q4 2025.
Genelux (GNLX) Non-Current Assets (2022 - 2026) Analysis & Trends
Genelux's Non-Current Assets history runs 5 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- On a quarterly basis, Non-Current Assets changed N/A year-over-year to $5.6 million in Q1 2026; TTM through Sep 2025 was $3.4 million, a 20.17% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, up 23.01% from the prior year.
- Non-Current Assets advanced to $5.6 million in Q1 2026 per GNLX's latest filing, from $3.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $10.3 million in Q2 2024 and bottomed at $2.9 million in Q3 2023.
- The 5-year median for Non-Current Assets is $3.6 million (2022), against an average of $4.3 million.
- Across the five-year window, Non-Current Assets jumped 48.74% in 2024 and slumped 70.78% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $3.6 million in 2022, then advanced by 1.4% to $3.7 million in 2023, then decreased by 14.15% to $3.2 million in 2024, then increased by 23.01% to $3.9 million in 2025, then surged by 44.16% to $5.6 million in 2026.
- Per Business Quant, the three latest GNLX Non-Current Assets figures stand at $5.6 million (Q1 2026), $3.9 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 5.83 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 30.30 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.95 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 285.82 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 10.31 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 2.89 Mn |
| Dec 31, 2022 | 3.64 Mn |